Clinical impact and molecular basis of antimicrobial resistance in non-baumannii Acinetobacter

Future Microbiology

Volumn 6, Issue 5, 2011, Pages 495-511

  Espinal, Paula ^a   Roca, Ignasi ^a   Vila, Jordi ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Acinetobacter; b lactamases; carbapenemases; efflux pumps; nosocomial infections; resistance mechanisms

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAM; CARBAPENEM; CEPHALOSPORINASE; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; GLYCYLCYCLINE DERIVATIVE; IMIPENEM; MEROPENEM; POLYMYXIN; QUINOLONE DERIVATIVE; SULTAMICILLIN; TIGECYCLINE;

ACINETOBACTER; ACINETOBACTER BAYLYI; ACINETOBACTER CALCOACETICUS; ACINETOBACTER GENOMOSPECIES; ACINETOBACTER HEMOLYTICUS; ACINETOBACTER INFECTION; ACINETOBACTER JOHNSONII; ACINETOBACTER JUNII; ACINETOBACTER LWOFFII; ACINETOBACTER PHENON; ACINETOBACTER RADIORESISTENS; ACINETOBACTER URSINGII; ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; CELL DIVISION; GENE MUTATION; GEOGRAPHIC DISTRIBUTION; HOSPITAL INFECTION; HUMAN; MOLECULAR TYPING; NEWBORN INTENSIVE CARE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; BETA-LACTAMS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; SPECIES SPECIFICITY;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER GENOMOSP. 13; ACINETOBACTER LWOFFII;

EID: 79956083506     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.11.30     Document Type: Review

References (127)

1. Peleg AY, Seifert H, Paterson DL: Acinetobacter baumannii: Emergence of a successful pathogen. Clin. Microbiol. Rev. 21, 538-582 (2008).
2. Towner, KJ: Acinetobacter: An old friend, but a new enemy. J. Hosp. Infect. 73, 355-363 (2009). • Brief review on Acinetobacter spp. presenting the common misconceptions.
3. Kampfer P, Tjernberg I, Ursing J: Numerical classification and identification of Acinetobacter genomic species. J. Appl. Bacteriol. 75, 259-268 (1993). (Pubitemid 23280802)
4. Gerner-Smidt P, Tjernberg, I: Acinetobacter in Denmark: II. Molecular studies of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex. APMIS 101, 826-832 (1993). (Pubitemid 24053931)
5. Vaneechoutte M, Dijkshoorn L, Tjernberg I et al.: Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis. J. Clin. Microbiol. 33, 11-15 (1995). (Pubitemid 24382389)
6. Ehrenstein B, Bernards AT, Dijkshoorn L et al.: Acinetobacter species identification by using tRNA spacer fingerprinting. J. Clin. Microbiol. 34, 2414-2420 (1996). (Pubitemid 26307783)
7. Janssen P, Maquelin K, Coopman R et al.: Discrimination of Acinetobacter genomic species by AFLP fingerprinting. Int. J. Syst. Bacteriol. 47, 1179-1187 (1997). (Pubitemid 27441250)
8. Durmaz R, Otlu B, Koksal F et al.: The optimization of a rapid pulsed-field gel electrophoresis protocol for the typing of Acinetobacter baumannii, Escherichia coli and Klebsiella spp. Jpn J. Infect. Dis. 62, 372-377 (2009).
9. Chang HC, Wei YF, Dijkshoorn L, Vaneechoutte M, Tang CT, Chang TC: Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. J. Clin. Microbiol. 43, 1632-1639 (2005).
10. Gundi VA, Dijkshoorn L, Burignat S, Raoult D, La Scola, B: Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species. Microbiology 155, 2333-2341 (2009).
11. Krawczyk B, Lewandowski K, Kur J: Comparative studies of the Acinetobacter genus and the species identification method based on the recA sequences. Mol. Cell Probes 16, 1-11 (2002). (Pubitemid 34246205)
12. Lin YC, Sheng WH, Chang SC et al.: Application of a microsphere-based array for rapid identification of Acinetobacter spp. with distinct antimicrobial susceptibilities. J. Clin. Microbiol. 46, 612-617 (2008).
13. Higgins PG, Wisplinghoff H, Krut O, Seifert H: A PCR-based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU. Clin. Microbiol. Infect. 13, 1199-1201 (2007).
14. Ecker JA, Massire C, Hall TA et al.: Identification of Acinetobacter species and genotyping of Acinetobacter baumannii by multilocus PCR and mass spectrometry. J. Clin. Microbiol. 44, 2921-2932 (2006). (Pubitemid 44228591)
15. van Dessel H, Kamp-Hopmans TE, Fluit AC et al.: Outbreak of a susceptible strain of Acinetobacter species 13 (sensu Tjernberg and Ursing) in an adult neurosurgical intensive care unit. J. Hosp. Infect. 51, 89-95 (2002). (Pubitemid 37554818)
16. Idzenga D, Schouten MA, van Zanten AR: Outbreak of Acinetobacter genomic species 3 in a Dutch intensive care unit. J. Hosp. Infect. 63, 485-487 (2006).
17. Horrevorts A, Bergman K, Kollee L, Breuker I, Tjernberg I, Dijkshoorn, L: Clinical and epidemiological investigations of Acinetobacter genomospecies 3 in a neonatal intensive care unit. J. Clin. Microbiol. 33, 1567-1572 (1995).
18. Mader K, Terhes G, Hajdu E et al.: Outbreak of septicaemic cases caused by Acinetobacter ursingii in a neonatal intensive care unit. Int. J. Med. Microbiol. 300, 338-340 (2010).
19. Kilic A, Li H, Mellmann A et al.: Acinetobacter septicus sp. nov. association with a nosocomial outbreak of bacteremia in a neonatal intensive care unit. J. Clin. Microbiol. 46, 902-908 (2008). (Pubitemid 351379977)
20. Seifert H, Baginski R, Schulze A, Pulverer G: The distribution of Acinetobacter species in clinical culture materials. Zentralbl. Bakteriol. 279, 544-552 (1993). (Pubitemid 2004863)
21. Turton JF, Shah J, Ozongwu C, Pike R: Incidence of Acinetobacter species other than A. baumannii among clinical isolates of Acinetobacter: Evidence for emerging species. J. Clin. Microbiol. 48, 1445-1449 (2010). • Study presenting the prevalence of the different species of the genus Acinetobacter among 690 isolates from hospitals in UK and Republic of Ireland, showing the emergence of some species.
22. Donnarumma F, Sergi S, Indorato C et al.: Molecular characterization of acinetobacter isolates collected in intensive care units of six hospitals in Florence, Italy, during a 3-year surveillance program: A population structure analysis. J. Clin. Microbiol. 48, 1297-1304 (2010).
23. van den Broek PJ, van der Reijden TJ, van Strijen E, Helmig-Schurter AV, Bernards AT, Dijkshoorn L: Endemic and epidemic Acinetobacter species in a university hospital: An 8-year survey. J. Clin. Microbiol. 47, 3593-3599 (2009).
24. Boo TW, Walsh F, Crowley, B: Molecular characterization of carbapenem-resistant Acinetobacter species in an Irish university hospital: Predominance of Acinetobacter genomic species 3. J. Med. Microbiol. 58, 209-216 (2009).
25. Molina J, Cisneros JM, Fernandez-Cuenca F et al.: Clinical features of infections and colonization by Acinetobacter genospecies 3. J. Clin. Microbiol. 48, 4623-4626 (2010). • First report analyzing the clinical differences among Acinetobacter genomospecies, finding that clinical features of genomospecies 3 may not be equivalent to those traditionally described for Acinetobacter baumannii.
26. Castellanos Martinez E, Telenti Asensio M, Rodriguez Blanco VM, Rodriguez Suarez ML, Morena Torrico A, Cortina Llosa A: Infective endocarditis of an interventricular patch caused by Acinetobacter haemolyticus. Infection 23, 243-245 (1995).
27. Kappstein I, Grundmann H, Hauer T, Niemeyer C: Aerators as a reservoir of Acinetobacter junii: An outbreak of bacteraemia in paediatric oncology patients. J. Hosp. Infect. 44, 27-30 (2000). (Pubitemid 30074332)
28. de Beaufort AJ, Bernards AT, Dijkshoorn L, van Boven CP: Acinetobacter junii causes life-threatening sepsis in preterm infants. Acta Paediatr. 88, 772-775 (1999). (Pubitemid 29350149)
29. Bernards AT, de Beaufort AJ, Dijkshoorn L, van Boven CP: Outbreak of septicaemia in neonates caused by Acinetobacter junii investigated by amplified ribosomal DNA restriction analysis (ARDRA) and four typing methods. J. Hosp. Infect. 35, 129-140 (1997). (Pubitemid 27141984)
30. Seifert H, Strate A, Schulze A, Pulverer G: Vascular catheter-related bloodstream infection due to Acinetobacter johnsonii (formerly Acinetobacter calcoaceticus var. lwoffi): Report of 13 cases. Clin. Infect. Dis. 17, 632-636 (1993). (Pubitemid 23293371)
31. Valero C, Farinas MC, Garcia Palomo D, Mazarrasa JC, Gonzalez Macias, J: Endocarditis due to Acinetobacter lwoffi on native mitral valve. Int. J. Cardiol. 69, 97-99 (1999). (Pubitemid 29225701)
32. Serrano MI, Solera J, Martinez E, Saez L: [Community-acquired meningitis caused by Acinetobacter calcoaceticus var. lwoffi in a healthy host]. Enferm. Infecc. Microbiol. Clin. 11, 396-397 (1993).
33. Crawford PM Jr, Conway MD, Peyman GA: Trauma-induced Acinetobacter lwoffii endophthalmitis with multi-organism recurrence: Strategies with intravitreal treatment. Eye (Lond.) 11(Pt 6), 863-864 (1997). (Pubitemid 28024957)
34. McDonald A, Amyes SG, Paton, R: The persistence and clonal spread of a single strain of Acinetobacter 13TU in a large Scottish teaching hospital. J. Chemother. 11, 338-344 (1999). (Pubitemid 29519206)
35. Karah N, Haldorsen B, Hegstad K et al.: Molecular identification and characterization of Acinetobacter spp. clinical isolates from Norway. Presented at: 8th International Symposium on the Biology of Acinetobacter. Rome, Italy, 1-3 September 2010.
36. Seifert H, Baginski R, Schulze A, Pulverer G: Antimicrobial susceptibility of Acinetobacter species. Antimicrob. Agents Chemother. 37, 750-753 (1993). (Pubitemid 23096873)
37. Ribera A, Fernandez-Cuenca F, Beceiro A et al.: Antimicrobial susceptibility and mechanisms of resistance to quinolones and b-lactams in Acinetobacter genospecies 3. Antimicrob. Agents Chemother. 48, 1430-1432 (2004). • Multicentric study in Spain describing resistance mechanisms in Acinetobacter genomospecies 3. (Pubitemid 38405513)
38. Lim YM, Shin KS, Kim J: Distinct antimicrobial resistance patterns and antimicrobial resistance-harboring genes according to genomic species of Acinetobacter isolates. J. Clin. Microbiol. 45, 902-905 (2007). (Pubitemid 46427709)
39. Henwood CJ, Gatward T, Warner M et al.: Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936). J. Antimicrob. Chemother. 49, 479-487 (2002). (Pubitemid 34223669)
40. Lin YC, Sheng WH, Chen YC, Chang SC, Hsia KC, Li SY: Differences in carbapenem resistance genes among Acinetobacter baumannii, Acinetobacter genospecies 3 and Acinetobacter genospecies 13TU in Taiwan. Int. J. Antimicrob. Agents 35, 439-443 (2010).
41. Lee YT, Huang LY, Chiang DH et al.: Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan. Int. J. Antimicrob. Agents 34, 580-584 (2009).
42. Van Looveren M, Goossens H: Antimicrobial resistance of Acinetobacter spp. in Europe. Clin. Microbiol. Infect. 10, 684-704 (2004). (Pubitemid 39232684)
43. Jain R, Danziger LH: Multidrug-resistant Acinetobacter infections: An emerging challenge to clinicians. Ann. Pharmacother. 38, 1449-1459 (2004). (Pubitemid 39100202)
44. Lee JH, Choi CH, Kang HY et al.: Differences in phenotypic and genotypic traits against antimicrobial agents between Acinetobacter baumannii and Acinetobacter genomic species 13TU. J. Antimicrob. Chemother. 59, 633-639 (2007). (Pubitemid 47073395)
45. Nordmann P, Poirel L: Emerging carbapenemases in Gram-negative aerobes. Clin. Microbiol. Infect. 8, 321-331 (2002). (Pubitemid 34993804)
46. Beceiro A, Dominguez L, Ribera A et al.: Molecular characterization of the gene encoding a new AmpC β-lactamase in a clinical strain of Acinetobacter genomic species 3. Antimicrob. Agents Chemother. 48, 1374-1378 (2004). (Pubitemid 38405499)
47. Beceiro A, Perez-Llarena FJ, Perez A et al.: Molecular characterization of the gene encoding a new AmpC β-lactamase in Acinetobacter baylyi. J. Antimicrob. Chemother. 59, 996-1000 (2007). (Pubitemid 47073373)
48. Bou G, Martinez-Beltran J: Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC β-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 44, 428-432 (2000). (Pubitemid 30060746)
49. Drawz SM, Babic M, Bethel CR et al.: Inhibition of the class C β-lactamase from Acinetobacter spp.: Insights into effective inhibitor design. Biochemistry 49, 329-340 (2010).
50. Hujer KM, Hamza NS, Hujer AM et al.: Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 β-lactamase: Defining a unique family of class C enzymes. Antimicrob. Agents Chemother. 49, 2941-2948 (2005). (Pubitemid 40917614)
51. Beceiro A, Perez A, Fernandez-Cuenca F et al.: Genetic variability among ampC genes from Acinetobacter genomic species 3. Antimicrob. Agents Chemother. 53, 1177-1184 (2009).
52. Lin YC, Hsia KC, Chen YC et al.: Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan. Antimicrob. Agents Chemother. 54, 2078-2084 (2010).
53. Bonomo RA, Szabo D: Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin. Infect. Dis. 43(Suppl. 2), S49-S56 (2006). (Pubitemid 44267140)
54. Yong D, Shin JH, Kim S et al.: High prevalence of PER-1 extended-spectrum β-lactamase-producing Acinetobacter spp. in Korea. Antimicrob. Agents Chemother. 47, 1749-1751 (2003). (Pubitemid 36548567)
55. Wang H, Guo P, Sun H et al.: Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrob. Agents Chemother. 51, 4022-4028 (2007). (Pubitemid 350057801)
56. Sacha P, Ostas A, Jaworowska J et al.: The KPC type β-lactamases: New enzymes that confer resistance to carbapenems in Gram-negative bacilli. Folia Histochem. Cytobiol. 47, 537-543 (2009).
57. Robledo IE, Aquino EE, Sante MI et al.: Detection of KPC in Acinetobacter spp. in Puerto Rico. Antimicrob. Agents Chemother. 54, 1354-1357 (2010).
58. Naas T, Cuzon G, Villegas MV, Lartigue MF, Quinn JP, Nordmann P: Genetic structures at the origin of acquisition of the β-lactamase bla KPC gene. Antimicrob. Agents Chemother. 52, 1257-1263 (2008). (Pubitemid 351521985)
59. Poirel L, Corvec S, Rapoport M et al.: Identification of the novel narrow-spectrum β-lactamase SCO-1 in Acinetobacter spp. from Argentina. Antimicrob. Agents Chemother. 51, 2179-2184 (2007). (Pubitemid 46903111)
60. Poirel L, Nordmann P: Carbapenem resistance in Acinetobacter baumannii: Mechanisms and epidemiology. Clin. Microbiol. Infect. 12, 826-836 (2006). (Pubitemid 44151282)
61. Kim CK, Lee Y, Lee H et al.: Prevalence and diversity of carbapenemases among imipenem-nonsusceptible Acinetobacter isolates in Korea: Emergence of a novel OXA-182. Diagn. Microbiol. Infect. Dis. 68, 432-438 (2010).
62. Queenan AM, Bush K: Carbapenemases: The versatile β-lactamases. Clin. Microbiol. Rev. 20, 440-458 (2007).
63. Poirel L, Pitout JD, Nordmann P: Carbapenemases: Molecular diversity and clinical consequences. Future Microbiol. 2, 501-512 (2007). (Pubitemid 47578214)
64. Rossolini GM: Acquired metallo-β-lactamases: An increasing clinical threat. Clin. Infect. Dis. 41, 1557-1558 (2005). (Pubitemid 41691592)
65. Houang ET, Chu YW, Chu KY, Ng KC, Leung CM, Cheng AF: Significance of genomic DNA group delineation in comparative studies of antimicrobial susceptibility of Acinetobacter spp. Antimicrob. Agents Chemother. 47, 1472-1475 (2003). (Pubitemid 36368624)
66. Lu PL, Huang LY, Lian ST, et al.: How carbapenem-resistant Acinetobacter spp. established in a newly constructed hospital. Int. J. Antimicrob. Agents 31, 463-466 (2008).
67. Yum JH, Yi K, Lee H, et al.: Molecular characterization of metallo-β-lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: Identification of two new integrons carrying the bla(VIM-2) gene cassettes. J. Antimicrob. Chemother. 49, 837-840 (2002). (Pubitemid 34537647)
68. Chu YW, Afzal-Shah M, Houang ET et al.: IMP-4, a novel metallo-β-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrob. Agents Chemother. 45, 710-714 (2001). (Pubitemid 32182013)
69. Lee K, Kim CK, Hong SG et al.: Characteristics of clinical isolates of Acinetobacter genomospecies 10 carrying two different metallo-β-lactamases. Int. J. Antimicrob. Agents 36, 259-263 (2010).
70. Woodford N, Ellington MJ, Coelho JM et al.: Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents 27, 351-353 (2006).
71. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA: Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 51, 3471-3484 (2007). (Pubitemid 47519332)
72. Poirel L, Naas T, Nordmann P: Diversity, epidemiology, and genetics of class D β-lactamases. Antimicrob. Agents Chemother. 54, 24-38 (2009).
73. Martí S, Sánchez-Céspedes J, Blasco MD et al.: Characterization of the carbapenem-hydrolyzing oxacillinase oxa-58 in an Acinetobacter genospecies 3 clinical isolate. Antimicrob. Agents Chemother. 52, 2955-2958 (2008).
74. Scaife W, Young HK, Paton RH, Amyes SG: Transferable imipenem-resistance in Acinetobacter species from a clinical source. J. Antimicrob. Chemother. 36, 585-586 (1995).
75. Poirel L, Marque S, Heritier C, Segonds C, Chabanon G, Nordmann P: OXA-58, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob. Agents Chemother. 49, 202-208 (2005). (Pubitemid 40065794)
76. Marque S, Poirel L, Heritier C et al.: Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe. J. Clin. Microbiol. 43, 4885-4888 (2005). (Pubitemid 41298303)
77. Martí S, Sánchez-Céspedes J, Blasco MD et al.: Characterization of the carbapenem-hydrolyzing oxacillinase OXA-58 in an Acinetobacter phenon 6/ct13TU clinical isolate. Diagn. Microbiol. Infect. Dis. 61, 468-470 (2008). (Pubitemid 351982005)
78. Evans BA, Hamouda A, Towner KJ, Amyes SG: Novel genetic context of multiple blaOXA-58 genes in Acinetobacter genospecies 3. J. Antimicrob. Chemother. 65, 1586-1588 (2010).
79. Poirel L, Figueiredo S, Cattoir V, Carattoli A, Nordmann P: Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp. Antimicrob. Agents Chemother. 52, 1252-1256 (2008). (Pubitemid 351521984)
80. OXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg. Infect. Dis. 16, 35-40 (2010).
81. Merino M, Acosta J, Poza M et al.: OXA-24 carbapenemase gene flanked by XerC/ XerD-like recombination sites in different plasmids from different Acinetobacter species isolated during a nosocomial outbreak. Antimicrob. Agents Chemother. 54, 2724-2727 (2010).
82. Mendes RE, Bell JM, Turnidge JD, Castanheira M, Jones RN: Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: Report from the SENTRY Surveillance Program. J. Antimicrob. Chemother. 63, 55-59 (2009). • Multicentric study analyzing occurrence and geographical distribution of carbapenemases in the Asia-Pacific region.
83. Traub WH, Bauer D: Surveillance of nosocomial cross-infections due to three Acinetobacter genospecies (Acinetobacter baumannii, genospecies 3 and genospecies 13) during a 10-year observation period: Serotyping, macrorestriction analysis of genomic DNA and antibiotic susceptibilities. Chemotherapy 46, 282-292 (2000). (Pubitemid 30428842)
84. Huang LY, Lu PL, Chen TL, Chang FY, Fung CP, Siu LK: Molecular characterization of β-lactamase genes and their genetic structures in Acinetobacter genospecies 3 isolates in Taiwan. Antimicrob. Agents Chemother. 54, 2699-2703 (2010).
85. Lambert T, Gerbaud G, Galimand M, Courvalin P: Characterization of Acinetobacter haemolyticus aac(6')-Ig gene encoding an aminoglycoside 51. Beceiro A, Perez A, Fernandez-Cuenca F et al.: Genetic variability among ampC genes from Acinetobacter genomic species 3. Antimicrob. Agents Chemother. 53, 1177-1184 (2009).
86. Doi Y, Wachino J, Yamane K et al.: Spread of novel aminoglycoside resistance gene aac(6')-Iad among Acinetobacter clinical isolates in Japan. Antimicrob. Agents Chemother. 48, 2075-2080 (2004). (Pubitemid 38691600)
87. Seward RJ, Lambert T, Towner KJ: Molecular epidemiology of aminoglycoside resistance in Acinetobacter spp. J. Med. Microbiol. 47, 455-462 (1998). (Pubitemid 28191050)
88. Vila J, Ruiz J, Goni P, Marcos A, Jimenez de Anta T: Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 39, 1201-1203 (1995).
89. Sheng WH, Lin YC, Wang JT et al.: Identification of distinct ciprofloxacin susceptibility in Acinetobacter spp. by detection of the gyrA gene mutation using real-time PCR. Mol. Cell. Probes 23, 154-156 (2009).
90. Piddock LJ: Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin. Microbiol. Rev. 19, 382-402 (2006).
91. Magnet S, Courvalin P, Lambert T: Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob. Agents Chemother. 45, 3375-3380 (2001). • First identification and characterization of a resistance-nodulation-cell division efflux pump in Acinetobacter. (Pubitemid 33107849)
92. Marchand I, Damier-Piolle L, Courvalin P, Lambert T: Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system. Antimicrob. Agents Chemother. 48, 3298-3304 (2004). (Pubitemid 39129322)
93. Ruzin A, Keeney D, Bradford PA: AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus- Acinetobacter baumannii complex. J. Antimicrob. Chemother. 59, 1001-1004 (2007). (Pubitemid 47073374)
94. Koh TH, Sng LH, Wang GC, Hsu LY, Zhao Y: Carbapenemase and efflux pump genes in Acinetobacter calcoaceticus- Acinetobacter baumannii complex strains from Singapore. J. Antimicrob. Chemother. 60, 1173-1174 (2007). (Pubitemid 47617775)
95. Chau SL, Chu YW, Houang ET: Novel resistance-nodulation-cell division efflux system AdeDE in Acinetobacter genomic DNA group 3. Antimicrob. Agents Chemother. 48, 4054-4055 (2004). (Pubitemid 39304648)
96. Chu YW, Chau SL, Houang ET: Presence of active efflux systems AdeABC, AdeDE and AdeXYZ in different Acinetobacter genomic DNA groups. J. Med. Microbiol. 55, 477-478 (2006).
97. Poole K: Efflux-mediated multiresistance in Gram-negative bacteria. Clin. Microbiol. Infect. 10, 12-26 (2004). (Pubitemid 38128588)
98. Nishino K, Yamaguchi A: Analysis of a complete library of putative drug transporter genes in Escherichia coli. J. Bacteriol. 183, 5803-5812 (2001). (Pubitemid 32917397)
99. Zhao Q, Li XZ, Srikumar R, Poole K: Contribution of outer membrane efflux protein OprM to antibiotic resistance in Pseudomonas aeruginosa independent of MexAB. Antimicrob. Agents Chemother. 42, 1682-1688 (1998). (Pubitemid 28311562)
100. Mine T, Morita Y, Kataoka A, Mizushima T, Tsuchiya T: Expression in Escherichia coli of a new multidrug efflux pump, MexXY, from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43, 415-417 (1999). (Pubitemid 29079189)
101. Alonso A, Martinez JL: Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 44, 3079-3086 (2000).
102. Damier-Piolle L, Magnet S, Brémont S, Lambert T, Courvalin P: AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii. Antimicrob. Agents Chemother. 52, 557-562 (2008). (Pubitemid 351170828)
103. Coyne S, Guigon G, Courvalin P, Perichon B: Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray. Antimicrob. Agents Chemother. 54, 333-340 (2010).
104. Coyne S, Rosenfeld N, Lambert T, Courvalin P, Perichon B: Overexpression of resistance-nodulation-cell division pump AdeFGH confers multidrug resistance in Acinetobacter baumannii. Antimicrob. Agents Chemother. 54, 4389-4393 (2010).
105. Huys G, Cnockaert M, Vaneechoutte M et al.: Distribution of tetracycline resistance genes in genotypically related and unrelated multiresistant Acinetobacter baumannii strains from different European hospitals. Res. Microbiol. 156, 348-355 (2005). (Pubitemid 40487456)
106. Nemec A, Maixnerova M, van der Reijden TJ, van den Broek PJ, Dijkshoorn L: Relationship between the AdeABC efflux system gene content, netilmicin susceptibility and multidrug resistance in a genotypically diverse collection of Acinetobacter baumannii strains. J. Antimicrob. Chemother. 60, 483-489 (2007). (Pubitemid 47299860)
107. Fournier PE, Vallenet D, Barbe V et al.: Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet. 2, E7 (2006).
108. Lin L, Ling BD, Li XZ: Distribution of the multidrug efflux pump genes, adeABC, adeDE and adeIJK, and class 1 integron genes in multiple-antimicrobial- resistant clinical isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex. Int. J. Antimicrob. Agents 33, 27-32 (2009). • Occurrence of different resistance- nodulation-cell division efflux pumps within the A. calcoaceticus-A. baumannii complex and involvement in resistance.
109. Roca I, Espinal P, Marti S, Vila J: First identification and characterization of an AdeABC-like efflux pump in Acinetobacter genomospecies 13TU. Antimicrob Agents Chemother. 55, 1285-1286 (2011).
110. Madden TL, Tatusov RL, Zhang, J: Applications of network BLAST server. Methods Enzymol. 266, 131-141 (1996). (Pubitemid 26165865)
111. Rajamohan G, Srinivasan VB, Gebreyes WA: Molecular and functional characterization of a novel efflux pump, AmvA, mediating antimicrobial and disinfectant resistance in Acinetobacter baumannii. J. Antimicrob. Chemother. 65, 1919-1925 (2010).
112. Ribera A, Roca I, Ruiz J, Gibert I, Vila J: Partial characterization of a transposon containing the tet(A) determinant in a clinical isolate of Acinetobacter baumannii. J. Antimicrob. Chemother. 52, 477-480 (2003). (Pubitemid 37120730)
113. Ribera A, Ruiz J, Vila J: Presence of the Tet M determinant in a clinical isolate of Acinetobacter baumannii. Antimicrob. Agents Chemother. 47, 2310-2312 (2003). (Pubitemid 36753589)
114. Roca I, Marti S, Espinal P, Martinez P, Gibert I, Vila J: CraA, a major facilitator superfamily efflux pump associated with chloramphenicol resistance in Acinetobacter baumannii. Antimicrob. Agents Chemother. 53, 4013-4014 (2009).
115. Srinivasan VB, Rajamohan G, Gebreyes WA: Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii. Antimicrob. Agents Chemother. 53, 5312-5316 (2009).
116. +-coupled Acinetobacter baumannii multidrug efflux pump belonging to the MATE family of transporters. Antimicrob. Agents Chemother. 49, 4362-4364 (2005). (Pubitemid 41400988)
117. Luna VA, Cousin S Jr, Whittington WL, Roberts MC: Identification of the conjugative mef gene in clinical Acinetobacter junii and Neisseria gonorrhoeae isolates. Antimicrob. Agents Chemother. 44, 2503-2506 (2000). (Pubitemid 30650902)
118. Vila J, Martí S, Sánchez-Céspedes J: Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J. Antimicrob. Chemother. 59, 1210-1215 (2007). (Pubitemid 47073338)
119. Agerso Y, Guardabassi L: Identification of Tet39, a novel class of tetracycline resistance determinant in Acinetobacter spp. of environmental and clinical origin. J. Antimicrob. Chemother. 55, 566-569 (2005). (Pubitemid 40542602)
120. Akers KS, Mende K, Yun HC et al.: Tetracycline susceptibility testing and resistance genes in isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex from a U.S. military hospital. Antimicrob. Agents Chemother. 53, 2693-2695 (2009).
121. Guardabassi L, Dijkshoorn L, Collard JM, Olsen JE, Dalsgaard A: Distribution and in-vitro transfer of tetracycline resistance determinants in clinical and aquatic Acinetobacter strains. J. Med. Microbiol. 49, 929-936 (2000).
122. Guardabassi L, Petersen A, Olsen JE, Dalsgaard A: Antibiotic resistance in Acinetobacter spp. isolated from sewers receiving waste effluent from a hospital and a pharmaceutical plant. Appl. Environ. Microbiol. 64, 3499-3502 (1998). (Pubitemid 28411480)
123. Vallenet D, Nordmann P, Barbe V et al.: Comparative analysis of Acinetobacters: Three genomes for three lifestyles. PLoS One 3, E1805 (2008).
124. Smith MG, Gianoulis TA, Pukatzki S et al.: New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev. 21, 601-614 (2007). (Pubitemid 46409474)
125. Barbe V, Vallenet D, Fonknechten N et al.: Unique features revealed by the genome sequence of Acinetobacter sp. ADP1, a versatile and naturally transformation competent bacterium. Nucleic Acids Res. 32, 5766-5779 (2004). (Pubitemid 39619160)
126. Vila J, Martinez JL: Clinical impact of the over-expression of efflux pump in nonfermentative Gram-negative bacilli, development of efflux pump inhibitors. Curr. Drug Targets 9, 797-807 (2008).
127. Martí S, Rodríguez-Baño J, Catel-Ferreira M et al.: Biofilm formation at the solid-liquid and air-liquid interfaces by Acinetobacter species. BMC Res. Notes 4, 5 (2011).